Herpes virus mutant points towards new vaccine strategy

December 19, 2017 by Laura Ruhge, Northwestern University
Axons, like those pictured above, are the so-called highways of the nervous system, which the herpes virus traffics to establish lifelong infection in a host. Credit: Laura Ruhge

A Northwestern Medicine study published in PLOS Pathogens describes a newly-designed mutant herpes virus called R2 that provides a strategy for the development of novel herpes virus vaccines.

Herpes simplex viruses, known for causing cold sores and , are two members of the alpha herpes family, which also includes the varicella-zoster virus, the cause of chickenpox. These viruses share a unique property: the ability to routinely and robustly infect the nervous system, establishing lifelong infection.

When a herpes virus initially enters a skin, or epithelial, cell, it begins shedding its outer layers, releasing viral proteins to perform their functions, but a small subset of viral proteins remains bound to the DNA-filled capsid, a shell that holds the DNA that will turn the cell into a herpes virus factory.

One of the proteins that escorts the DNA-filled capsid is the focus of the current study. Collaborators at Tufts University found that this protein, called protein UL37, has three distinct regions conserved in alpha herpes viruses, and the scientists discovered that mutating the second region, termed R2, exhibited an exciting trait.

Lead author Alexsia Richards, Ph.D., a former postdoctoral fellow in the laboratory of senior author Gregory Smith, Ph.D., professor of Microbiology-Immunology, explained that although the R2 mutant successfully infected epithelial cells, the virus failed to infect neurons.

The scientists discovered that R2 could enter neurons but once inside, it simply bounces back and forth, unable to travel the long distances needed to reach the nucleus of a neuronal cell where latent—or lifelong—infection is established.

To further understand these results, the scientists turned to mouse models. Using another alpha herpes virus that normally infects pigs, the scientists saw that mice infected with the unmodified version of the virus died rapidly, but all of the mice infected with the R2 mutant survived.

These photos show a fluorescent herpes virus spreading in the tissues of a mouse. The virus is found in the mouse eye after infection of the cornea (top left) and proficiently invades the nervous system (top right). When mice are infected with the R2 mutant, the virus spreads in the mouse eye (bottom left) but is not detected in the nervous system (bottom right). Credit: Northwestern University

Next, the scientists investigated whether the R2 mutant can vaccinate mice. Collaborators at the University of Nebraska-Lincoln exposed mice to the R2 mutant, waited several days, and then infected the mice with 10,000 times the lethal dose normally required to kill 50 percent of the mice. They found that 75 percent of the vaccinated survived the lethal experiment with no signs of infection.

"We now have a virus with this unique property that had never been seen before: a virus that can propagate just like a wild-type herpes virus but specifically can't travel into the nerves and go latent in the nervous system," Smith said.

Furthermore, because mutating R2 produces an effect both in human and animal herpes viruses, the authors believe they've created a tool for a new generation of herpes virus vaccines.

"It's basically a tool to make any strain you want," Richards said.

The authors note that the R2 mutation findings have the potential to improve currently approved vaccines, like the chickenpox virus vaccine.

Future research will focus on further developing the R2 mutant as a master vaccine.

"We are amazed by the efficacy of this vaccine, but this gets to the point where basically you need to partner with a pharmaceutical company. The hope would be that once the paper is out, and people start seeing the efficacy of this approach, they'll take interest and there'll be people that want to try and push this forward with our help," Smith said.

Explore further: Newfound protein may prevent viral infection and herpes-induced cancer

More information: Alexsia L. Richards et al. The pUL37 tegument protein guides alpha-herpesvirus retrograde axonal transport to promote neuroinvasion, PLOS Pathogens (2017). DOI: 10.1371/journal.ppat.1006741

Related Stories

Newfound protein may prevent viral infection and herpes-induced cancer

November 28, 2017
Keck School of Medicine of USC researchers have identified a human protein that could prevent cancer by restricting a type of herpes virus from replicating.

Preclinical evaluation of a vaccine against herpes viruses

August 4, 2016
Oral and genital herpes are caused by the herpes simplex virus type 1 (HSV-1) and the herpes simplex virus type 2 (HSV-2), which both cause lifelong infection. HSV-2 infection is associated with increased risk for HIV infection. ...

Chimera viruses can help the fight against lymphomas

September 15, 2017
Researchers from Instituto de Medicina Molecular (iMM) Lisboa have created a chimera virus that allows the study of molecules to treat cancers caused by human herpes virus infection in mice models of disease.

Constipated? Study finds surprising cause

June 8, 2016
A Yale-led study has shown a surprising link between constipation and herpes infection. The finding, published June 8 in Cell Host & Microbe, advances the science on herpes, and could help patients with chronic gastrointestinal ...

Study reveals new approach for stopping herpes infections

March 25, 2013
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a novel strategy for preventing infections due to the highly common herpes simplex viruses, the microbes responsible for causing genital ...

Novel vaccine reduces shedding of genital herpes virus

September 12, 2013
Sexually transmitted infection researchers potentially have reached a milestone in vaccine treatment for genital herpes, according to a report to be presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy ...

Recommended for you

Researchers seek vaccine for 'traveler's diarrhea'

September 25, 2018
Every year, millions of people have vacations and business trips ruined when they succumb to "traveler's diarrhea" during their journeys. A major cause of traveler's diarrhea is bacteria called Enterotoxigenic E. coli, or ...

Experimental vaccine shows promise in preventing TB

September 25, 2018
(HealthDay)—Tuberculosis remains the most lethal of infectious diseases worldwide, killing more than 1.6 million people a year. But researchers say a new vaccine might prevent half of full-blown illnesses in infected people ...

Many doctors in India miss TB signs: study

September 25, 2018
Many private sector doctors in India miss the signs of tuberculosis and therefore provide patients inadequate treatment, according to a new study published Tuesday involving people hired to act out the symptoms.

New way of determining treatment for staph infections cuts antibiotic use

September 25, 2018
Using a clinical checklist to identify eligible patients, doctors were able to shorten the antibiotic duration for patients with uncomplicated staphylococcal bloodstream infections by nearly two days, Duke Health researchers ...

Breakthrough in designing a better Salmonella vaccine

September 24, 2018
UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing ...

Antifungal agent found to be possible treatment for porphyria

September 24, 2018
A large team of researchers from Spain, France and the U.S. has found that a common antifungal agent might be useful as a treatment for a rare type of porphyria. In their paper published in the journal Science Translational ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

joymiss2123
1 / 5 (1) Jan 28, 2018
TESTIMONY OF HOW I GOT CURED FROM HERPES
This is real take it serious, who will believe that herbs can cure Cance , i never believe it will work, i have spend a lot, getting drugs from the hospital to keep me healthy, but it got to a time when there was nothing left in me again because i was so broke, one day a friend introduce this great man to me on line called DR IMONAH who is well know for herpes cancer and hepatitis diabetes cure, i decided to email him but I never thought herbals can cure herpes , though I just wanted to give him a try, he replied my mail and Needed some Information about me, then I sent them to him, he prepared a herbal medicine (CURE) and sent it through Courier Service for delivery, the Courier Office told me that 3-5 days I will receive the package and after receiving it, i took the medicine as prescribed by him at the end of one month, he told me to go to the hospital for a check up, and i went, surprisingly after the test the doctor confirm me cancer

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.